Scott D. Baskin - 07 Aug 2025 Form 4 Insider Report for AMERICAN VANGUARD CORP (AVD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Aug 2025, 20:00:23 UTC
Prior SEC filing
06 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ SCOTT D. BASKIN

Key filing fact

Scott D. Baskin filed Form 4 for AMERICAN VANGUARD CORP (AVD) on 08 Aug 2025.

Key facts

  • This page summarizes Scott D. Baskin's Form 4 filing for AMERICAN VANGUARD CORP (AVD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Aug 2025, 20:00.

Change

  • Previous filing in this sequence was filed on 06 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001595727 Primary reporting owner

Baskin Scott

Relationship
Director
Address
4695 MACARTHUR COURT, STE 1200, NEWPORT BEACH
Signature
/s/ SCOTT D. BASKIN
Signature date
08 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVD transaction

Common Stock

Award

Transaction value
$0
Shares
+8,810
Change %
+27%
Price
$0.000000
Shares after
41,997
Date
07 Aug 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were awarded as part of the Company's compensation program for non-management directors in connection with the 2025 annual stockholders' meeting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .